Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$8.58 USD
-0.04 (-0.46%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $8.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Recursion Pharmaceuticals, Inc. [RXRX]
Reports for Purchase
Showing records 41 - 60 ( 86 total )
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Download Day Highlights Vast and Growing Data, Clinical Program Progress and Financial Targets
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare IT: Recap from Large HC Industry Conference
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
New Investor Presentation Details Near & Medium-Term Milestone Targets and Current Therapeutic Pipeline
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Recursion Pharmaceuticals, Inc.
Industry: Medical - Drugs
3Q Revenue Beat and Positive Business Updates
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department